Eritadenine-induced alterations of plasma lipoprotein lipid concentrations and phosphatidylcholine molecular species profile in rats fed cholesterol-free and cholesterol-enriched diets.
The effects of dietary eritadenine on the concentration of plasma lipoprotein lipids and the molecular species profile of plasma lipoprotein phosphatidylcholine (PC) were investigated in rats fed cholesterol-free and cholesterol-enriched diets to obtain insights into the relationship between the changes in PC molecular species profile and the hypocholesterolemic action of eritadenine. The effect of eritadenine on the secretion rate of very low density lipoprotein (VLDL) from the liver was also estimated. Rats were fed the control or eritadenine-supplemented (50 mg/kg) diets with or without exogenous cholesterol for 14 d. Eritadenine supplementation significantly decreased the cholesterol of major plasma lipoproteins, high density lipoprotein and VLDL, in rats fed cholesterol-free and cholesterol-enriched diets, respectively. The ratio of PC to phosphatidylethanolamine, delta6-desaturase activity, and the ratio of arachidonic acid to linoleic acid in liver microsomes were markedly decreased by eritadenine irrespective of the presence or absence of exogenous cholesterol. Dietary eritadenine increased the proportion of 16:0-18:2 molecular species with a decrease in 18:0-20:4 in plasma lipoprotein PC in both rats fed cholesterol-free and cholesterol-enriched diets. Eritadenine did not depress the secretion rate of VLDL in rats fed a cholesterol-free diet containing a high level of choline. The results indicate that dietary eritadenine elicits its hypocholesterolemic action with modulations of the fatty acid and molecular species profiles of PC irrespective of the presence or absence of exogenous cholesterol. The eritadenine-induced alteration of PC molecular species profile is discussed in relation to the hypocholesterolemic action of eritadenine.
Shimada
Yasuhiko
Y
Department of Applied Biological Chemistry, Faculty of Agriculture, Shizuoka University, Shizuoka 422-8529, Japan.
Morita
Tatsuya
T
Sugiyama
Kimio
K
D000225:Adenine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D002791:Cholesterol, Dietary / Q000378:metabolism / Q000494:pharmacology*; D002794:Choline / Q000494:pharmacology; D004032:Diet; D004075:Diglycerides / Q000737:chemistry / Q000378:metabolism; D004435:Eating / Q000187:drug effects; D044943:Fatty Acid Desaturases / Q000378:metabolism; D006128:Growth / Q000187:drug effects; D050602:Linoleoyl-CoA Desaturase; D008074:Lipoproteins / Q000097:blood*; D008079:Lipoproteins, VLDL / Q000378:metabolism; D008082:Lipotropic Agents / Q000494:pharmacology; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008862:Microsomes, Liver / Q000187:drug effects / Q000378:metabolism; D009929:Organ Size / Q000187:drug effects; D010713:Phosphatidylcholines / Q000097:blood* / Q000737:chemistry; D051381:Rats; D017208:Rats, Wistar
D000924:Anticholesteremic Agents; D002791:Cholesterol, Dietary; D004075:Diglycerides; D008074:Lipoproteins; D008079:Lipoproteins, VLDL; D008082:Lipotropic Agents; D010713:Phosphatidylcholines; C100029:eritadenine; D044943:Fatty Acid Desaturases; D050602:Linoleoyl-CoA Desaturase; D000225:Adenine; D002794:Choline